International Consultation on Urologic Diseases and the European Association of Urology International Consultation on Locally Advanced Renal Cell Carcinoma

Leibovich, 2006, Surgical management of renal cell carcinoma, Semin Oncol, 33, 552, 10.1053/j.seminoncol.2006.06.007 Jacobsohn, 2006, Adjuvant therapy for renal cell carcinoma, Semin Oncol, 33, 576, 10.1053/j.seminoncol.2006.06.005 Haas, 2008, Adjuvant therapy for renal cell carcinoma, Curr Oncol Rep, 10, 245, 10.1007/s11912-008-0037-4 Marshall, 1970, Surgery for renal cell carcinoma in the vena cava, J Urol, 103, 414, 10.1016/S0022-5347(17)61970-0 Blute, 2004, The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus, BJU Int, 94, 33, 10.1111/j.1464-410X.2004.04897.x Boorjian, 2007, Renal cell carcinoma: vena caval involvement, BJU Int, 99, 1239, 10.1111/j.1464-410X.2007.06826.x Oto, 1998, Inferior vena cava tumor thrombus in renal cell carcinoma: staging by MR imaging and impact on surgical treatment, AJR Am J Roentgenol, 171, 1619, 10.2214/ajr.171.6.9843299 Guzzo, 2009, The accuracy of multidetector computerized tomography for evaluating tumor thrombus in patients with renal cell carcinoma, J Urol, 181, 486, 10.1016/j.juro.2008.10.040 Karakiewicz, 2008, Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi, Eur Urol, 53, 845, 10.1016/j.eururo.2007.11.006 Di Silverio, 2008, Neoadjuvant therapy with sorafenib in advanced renal cell carcinoma with vena cava extension submitted to radical nephrectomy, Urol Int, 80, 451, 10.1159/000132708 Shuch, 2008, Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm, BJU Int, 102, 692, 10.1111/j.1464-410X.2008.07660.x Cost, 2011, The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus, Eur Urol, 59, 912, 10.1016/j.eururo.2011.02.032 Haferkamp, 2007, Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup, J Urol, 177, 1703, 10.1016/j.juro.2007.01.039 Subramanian, 2009, Utility of preoperative renal artery embolization for management of renal tumors with inferior vena caval thrombi, Urology, 74, 154, 10.1016/j.urology.2008.12.084 Henderson, 2008, Hand-assisted laparoscopic nephrectomy for renal cell cancer with renal vein tumor thrombus, Urology, 72, 268, 10.1016/j.urology.2008.02.026 Martin, 2008, Outcomes of laparoscopic radical nephrectomy in the setting of vena caval and renal vein thrombus: seven-year experience, J Endourol, 22, 1681, 10.1089/end.2008.0035 Rogers, 2008, Robotic nephrectomy for kidney cancer in a horseshoe kidney with renal vein tumor thrombus: novel technique for thrombectomy, J Endourol, 22, 1561, 10.1089/end.2008.0043 Bertini, 2008, Radical nephrocapsulectomy and caval thrombectomy with extracorporeal circulation and deep hypothermic circulatory arrest in right anterior minithoracotomy: a minimally invasive approach, Urology, 71, 957, 10.1016/j.urology.2007.11.122 Mazzola, 2007, Cavoatrial tumor thrombectomy with systemic circulatory arrest and antegrade cerebral perfusion, Ann Thorac Surg, 83, 1564, 10.1016/j.athoracsur.2006.04.028 Chowdhury, 2007, Novel techniques for tumor thrombectomy for renal cell carcinoma with intraatrial tumor thrombus, Ann Thorac Surg, 83, 1731, 10.1016/j.athoracsur.2006.12.055 Granberg, 2008, Surgical management, complications, and outcome of radical nephrectomy with inferior vena cava tumor thrombectomy facilitated by vascular bypass, Urology, 72, 148, 10.1016/j.urology.2008.01.006 Blute, 2007, Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy, J Urol, 178, 440, 10.1016/j.juro.2007.03.121 Hatcher, 1991, Surgical management and prognosis of renal cell carcinoma invading the vena cava, J Urol, 145, 20, 10.1016/S0022-5347(17)38235-6 Kim, 2004, Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?, J Urol, 171, 588, 10.1097/01.ju.0000104672.37029.4b Leibovich, 2005, Cancer specific survival for patients with pT3 renal cell carcinoma—can the 2002 primary tumor classification be improved?, J Urol, 173, 716, 10.1097/01.ju.0000151830.27750.d2 Marshall, 1988, Surgical management of renal cell carcinoma with intracaval neoplastic extension above the hepatic veins, J Urol, 139, 1166, 10.1016/S0022-5347(17)42848-5 Montie, 1991, Resection of inferior vena cava tumor thrombi from renal cell carcinoma, Am Surg, 57, 56 Neves, 1987, Surgical treatment of renal cancer with vena cava extension, Br J Urol, 59, 390, 10.1111/j.1464-410X.1987.tb04832.x Novick, 1990, Experience with cardiopulmonary bypass and deep hypothermic circulatory arrest in the management of retroperitoneal tumors with large vena caval thrombi, Ann Surg, 212, 472, 10.1097/00000658-199010000-00010 Reissigl, 1995, Renal cell carcinoma extending into the vena cava: surgical approach, technique and results, Br J Urol, 75, 138, 10.1111/j.1464-410X.1995.tb07300.x Swierzewski, 1994, Radical nephrectomy in patients with renal cell carcinoma with venous, vena caval, and atrial extension, Am J Surg, 168, 205, 10.1016/S0002-9610(94)80069-3 Moinzadeh, 2004, Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same?, J Urol, 171, 598, 10.1097/01.ju.0000108842.27907.47 Pantuck, 2003, Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection, J Urol, 169, 2076, 10.1097/01.ju.0000066130.27119.1c Canfield, 2006, Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome, J Urol, 175, 864, 10.1016/S0022-5347(05)00334-4 Karakiewicz, 2007, Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival, Eur Urol, 51, 1616, 10.1016/j.eururo.2006.12.015 Delacroix S, Chapin BF, Chen JJ, et al. Can a durable disease free survival be achieved with surgical resection in patients with pathologic node positive renal cell carcinoma? J Urol. In press. Whitson, 2011, Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases, J Urol, 185, 1615, 10.1016/j.juro.2010.12.053 Blom, 1992, Radical nephrectomy with and without lymph node dissection: preliminary results of EORTC Protocol 30881. The EORTC Genitourinary Group, Prog Clin Biol Res, 378, 161 Vasselli, 2001, Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma, J Urol, 166, 68, 10.1016/S0022-5347(05)66078-8 Blute, 2004, A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma, J Urol, 172, 465, 10.1097/01.ju.0000129815.91927.85 Thompson, 2008, Preoperative nomogram to predict positive lymph nodes during nephrectomy for renal cell carcinoma, J Urol, 179, 2146, 10.1016/S0022-5347(08)60611-4 Terrone, 2003, The number of lymph nodes examined and staging accuracy in renal cell carcinoma, BJU Int, 91, 37, 10.1046/j.1464-410X.2003.04017.x Joslyn, 2005, Impact of lymphadenectomy and nodal burden in renal cell carcinoma: retrospective analysis of the National Surveillance, Epidemiology, and End Results database, Urology, 65, 675, 10.1016/j.urology.2004.10.068 Parker, 1935, Studies on the main posterior lymph channels of the abdomen and their connections with the lymphatics of the genito-urinary system, Am J Anat, 56, 409, 10.1002/aja.1000560305 Crispen, 2011, Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates, Eur Urol, 59, 18, 10.1016/j.eururo.2010.08.042 Margulis, 2007, Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management, Cancer, 109, 2025, 10.1002/cncr.22629 Karellas, 2009, Advanced-stage renal cell carcinoma treated by radical nephrectomy and adjacent organ or structure resection, BJU Int, 103, 160, 10.1111/j.1464-410X.2008.08025.x Capitanio, 2009, Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma), BJU Int, 104, 795, 10.1111/j.1464-410X.2009.08484.x Hock, 2002, Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data, J Urol, 167, 57, 10.1016/S0022-5347(05)65382-7 Manjunath, 2007, Surgical resection for locally invasive renal cell carcinoma: Is it worthwhile?, Indian J Urol, 23, 246, 10.4103/0970-1591.33444 Bex, 2009, Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery, World J Urol, 27, 533, 10.1007/s00345-008-0368-7 La Rochelle, 2010, Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma, Cancer, 116, 4696, 10.1002/cncr.25279 Pizzocaro, 1986, Adjuvant medroxyprogesterone acetate and steroid hormone receptors in category M0 renal cell carcinoma. An interim report of a prospective randomized study, J Urol, 135, 18, 10.1016/S0022-5347(17)45501-7 Pizzocaro, 1987, Adjuvant medroxyprogesterone acetate to radical nephrectomy in renal cancer: 5-year results of a prospective randomized study, J Urol, 138, 1379, 10.1016/S0022-5347(17)43647-0 Makarewicz, 1998, The value of postoperative radiotherapy in advanced renal cell cancer, Neoplasma, 45, 380 Rodriguez, 2006, Management of locally advanced renal cell carcinoma, Cancer Control, 13, 199, 10.1177/107327480601300307 Atzpodien, 2005, Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN), Br J Cancer, 92, 843, 10.1038/sj.bjc.6602443 Mulders, 2002, The role of adjuvant immunotherapy in renal cell carcinoma, Curr Urol Rep, 3, 44, 10.1007/s11934-002-0010-y Jeon, 1999, The role of adjuvant immunotherapy after radical nephrectomy and prognostic factors in pT3N0M0 renal cell carcinoma, Anticancer Res, 19, 5593 Basting, 1999, Adjuvant immunotherapy in renal cell carcinoma—comparison of interferon alpha treatment with an untreated control, Anticancer Res, 19, 1545 Migliari, 1995, Is there a role for adjuvant immunochemotherapy after radical nephrectomy in pT2-3N0M0 renal cell carcinoma?, J Chemother, 7, 240, 10.1179/joc.1995.7.3.240 Repmann, 2003, Adjuvant therapy of renal cell carcinoma patients with an autologous tumor cell lysate vaccine: a 5-year follow-up analysis, Anticancer Res, 23, 969 Wood, 2008, An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial, Lancet, 372, 145, 10.1016/S0140-6736(08)60697-2 Uemura, 2008, Tumor vaccines in renal cell carcinoma, World J Urol, 26, 147, 10.1007/s00345-008-0246-3 Kubler, 2006, Vaccines in renal cell carcinoma, Semin Oncol, 33, 614, 10.1053/j.seminoncol.2006.06.011 Jocham, 2004, Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial, Lancet, 363, 594, 10.1016/S0140-6736(04)15590-6 Galligioni, 1996, Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and bacillus Calmette-Guérin: five-year results of a prospective randomized study, Cancer, 77, 2560, 10.1002/(SICI)1097-0142(19960615)77:12<2560::AID-CNCR20>3.0.CO;2-P Margulis, 2009, Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinoma, Urology, 73, 337, 10.1016/j.urology.2008.08.476 Kapoor, 2009, Adjuvant and neoadjuvant small-molecule targeted therapy in high-risk renal cell carcinoma, Curr Oncol, 16, S60 Kunkle, 2007, Adjuvant therapy for high-risk renal cell carcinoma patients, Curr Urol Rep, 8, 19, 10.1007/s11934-007-0017-5 Wood, 2008, Adjuvant approaches to renal cell carcinoma, Clin Adv Hematol Oncol, 6, 19 Kalman, 1999, The role of arterial embolization in renal cell carcinoma, Scand J Urol Nephrol, 33, 162, 10.1080/003655999750015934 Zielinski, 2000, Comparison of preoperative embolization followed by radical nephrectomy with radical nephrectomy alone for renal cell carcinoma, Am J Clin Oncol, 23, 6, 10.1097/00000421-200002000-00002 Spencer, 1992, Immunotherapy with interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer with in situ primary cancers: a pilot study, J Urol, 147, 24, 10.1016/S0022-5347(17)37124-0 Wagner, 1999, Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in place, J Urol, 162, 43, 10.1097/00005392-199907000-00011 van der Veldt, 2008, Sunitinib for treatment of advanced renal cell cancer: primary tumor response, Clin Cancer Res, 14, 2431, 10.1158/1078-0432.CCR-07-4089 Silberstein, 2010, Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery, BJU Int, 106, 1270, 10.1111/j.1464-410X.2010.09357.x Cowey, 2010, Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma, J Clin Oncol, 28, 1502, 10.1200/JCO.2009.24.7759 Jonasch, 2009, Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma, J Clin Oncol, 27, 4076, 10.1200/JCO.2008.21.3660 Wood, 2009, Neoadjuvant (presurgical) therapy for renal cell carcinoma: a new treatment paradigm for locally advanced and metastatic disease, Cancer, 115, 2355, 10.1002/cncr.24240 Margulis, 2008, Cytoreductive nephrectomy in the era of targeted molecular agents: is it time to consider presurgical systemic therapy?, Eur Urol, 54, 489, 10.1016/j.eururo.2007.12.041 Margulis, 2009, Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma, J Urol, 181, 2044, 10.1016/j.juro.2009.01.043 Esrig, 1992, Experience with fossa recurrence of renal cell carcinoma, J Urol, 147, 1491, 10.1016/S0022-5347(17)37605-X Tanguay, 1996, Therapy of locally recurrent renal cell carcinoma after nephrectomy, J Urol, 155, 26, 10.1016/S0022-5347(01)66529-7 Itano, 2000, Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy, J Urol, 164, 322, 10.1016/S0022-5347(05)67350-8 Karam, 2011, Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma, J Urol, 185, 439, 10.1016/j.juro.2010.09.086